前列腺癌主动监测患者的长期健康相关生活质量:一项系统综述
该系统综述评估主动监测(AS)患者长期心理健康、性功能和泌尿功能的患者报告结局。检索获得1854条引文,纳入19篇论文,涉及3643例AS患者、14651例接受手术或放疗的患者及2478例无前列腺癌对照。AS患者健康相关生活质量优于或类似于手术或放疗患者,与无前列腺癌个体相当。
要点
- AS患者长期健康相关生活质量优于或类似于手术或放疗患者。
- AS患者长期健康相关生活质量与无前列腺癌个体相当。
- AS应继续作为经过适当选择患者的推荐管理策略。
核心结论
- AS患者报告的生活质量良好,与无前列腺癌个体相似;AS应继续作为经过适当选择患者的推荐管理策略。
研究设计与样本
- 系统综述,遵循系统综述和Meta分析优先报告条目(PRISMA)指南,纳入随访至少5年的AS患者中评估健康相关生活质量及性功能和泌尿功能经验证患者报告结局的系列研究。
- 检索获得1854条引文,纳入19篇论文,涉及3643例AS患者、14651例接受手术或放疗的患者和2478例无前列腺癌对照。
主要发现
- 在10项研究中,组间在性功能和泌尿症状方面观察到主要差异,如AS患者性功能更好、刺激性泌尿症状更少,但总体功能结局相当。
- 在所有研究中,AS患者的健康相关生活质量优于或类似于接受手术或放疗的患者,并与无癌症个体相当。
临床怎么用
- AS应继续作为经过适当选择患者的推荐管理策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Active surveillance (AS) represents the preferred treatment option in patients with low-risk prostate cancer. Optimised patient selection has enabled more patients to be managed with AS for a longer time. Thus, there is growing interest in its effect on long-term quality of life compared with interventional management. OBJECTIVE: To perform a systematic review evaluating the long-term patient-reported outcomes regarding mental health, and sexual and urinary function in patients on AS. EVIDENCE ACQUISITION: We performed a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. We included series assessing validated patient-reported outcomes of health-related quality of life, and sexual and urinary function in AS patients followed up for at least 5 yr. EVIDENCE SYNTHESIS: Our search yielded 1854 citations, including 19 papers involving 3643 patients on AS, 14 651 patients receiving surgery or radiotherapy, and 2478 controls without prostate cancer. In ten studies, major differences were observed in sexual and urinary symptoms between groups, such as better sexual function and fewer irritative urinary symptoms in patients on AS, though overall functional outcomes were comparable. In all studies, health-related quality of life for patients on AS was better than, or similar to, that for patients who had undergone surgery or radiotherapy and comparable with that for individuals without cancer. CONCLUSIONS: We observed differences in specific functional outcomes between patients on AS and surgery or radiotherapy, ≥5 yr after treatment. Patients on AS reported good quality of life, similar to that in individuals without prostate cancer. AS should continue to be a recommended management strategy for appropriately selected patients. PATIENT SUMMARY: Active surveillance is an accepted pathway for patients with low-risk localised prostate cancer. Previous literature has shown that it did not negatively affect short-term quality of life. This review finds that long-term quality of life for these patients is similar to that for people without prostate cancer.
引用
- Thompson D, Bensley JG, Tempo J, et al. Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review. Eur Urol Oncol. 2022. PMID: 36156268. doi:10.1016/j.euo.2022.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。